Global Vascular Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$6.93M
- Investors
-
13
Global Vascular General Information
Description
Developer of a drug-eluting stent delivery system designed for the treatment of lower limb artery disease. The company's nanotechnology suppresses thrombus adhesion and allows cell integration with the stent without inhibiting it, helping medical staff to undergo stent treatment on the patients while being gentle on the body
Contact Information
Website
www.g-vasc.comCorporate Office
- Mirio Jimbocho 11 Floor
- 1-28-1 Kanda Jimbocho, Chiyoda-ku
- Tokyo
- Japan
Corporate Office
- Mirio Jimbocho 11 Floor
- 1-28-1 Kanda Jimbocho, Chiyoda-ku
- Tokyo
- Japan
Global Vascular Timeline
Global Vascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series B) | 24-Jun-2025 | $6.93M | Completed | Generating Revenue | ||
| 4. Early Stage VC (Series A) | 05-Dec-2023 | Completed | Generating Revenue | |||
| 3. Seed Round | 10-May-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | 01-Jan-2022 | Completed | Startup |
Global Vascular Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class B Preferred | ||||||||
| Class A Preferred | ||||||||
| Ordinary Shares | 857,143 | $2.02 | $2.02 | 1x | $2.02 | 5.19% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Global Vascular Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Medikit (Diagnostic Equipment) | Corporation | Minority | ||
| Mitsui Sumitomo Kaijo Capital | Corporate Venture Capital | Minority | ||
| Sumitomo Mitsui Trust Bank | Investment Bank | Minority | ||
| Tokyo University of Science Innovation Capital | Corporation | Minority | ||
| Fast Track Initiative | Venture Capital | Minority |
Global Vascular FAQs
-
When was Global Vascular founded?
Global Vascular was founded in 2022.
-
Where is Global Vascular headquartered?
Global Vascular is headquartered in Tokyo, Japan.
-
What industry is Global Vascular in?
Global Vascular’s primary industry is Drug Delivery.
-
Is Global Vascular a private or public company?
Global Vascular is a Private company.
-
What is the current valuation of Global Vascular?
The current valuation of Global Vascular is .
-
What is Global Vascular’s current revenue?
The current revenue for Global Vascular is .
-
How much funding has Global Vascular raised over time?
Global Vascular has raised $18.8M.
-
Who are Global Vascular’s investors?
Medikit (Diagnostic Equipment), Mitsui Sumitomo Kaijo Capital, Sumitomo Mitsui Trust Bank, Tokyo University of Science Innovation Capital, and Fast Track Initiative are 5 of 13 investors who have invested in Global Vascular.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process